U.S. stock-index futures turned positive on Friday after a report from Gilead Sciences indicated that its experimental treatment for coronavirus was seeing positive results in reducing deaths. Futures for the Dow Jones Industrial Average YM00, +0.06% YMU20, +0.06% were up 0.1% at 25,600, those for the S&P 500 index ES00, +0.05% ESU20, +0.05% were trading up 0.
1% at 3,144, while Nasdaq-100 futures NQ00, +0.11% NQU20, +0.11% advanced 0.1% at 10,740. Gilead published a report on Friday saying that its antiviral drug remdesivir showed that it reduced the risk of death for coronavirus patients by 62% compared with standard care alone. The findings are being presented at the Virtual Covid-19 Conference as part of the 23rd International AIDS Conference, the company said.
😂😂
Dejavú
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
Источник: MarketWatch - 🏆 3. / 97 Прочитайте больше »